WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 40'0801 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 36'9821 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 4'661  4'615  4'567  4'518  4'468  3'859  3'398  3'147 
Births 62  62  62  62  62  56  57  51 
Surviving infants 61  61  61  62  62  55  57  50 
Pop. less than 5 years 304  309  311  315  319  283  276  257 
Pop. less than 15 years 924  922  917  914  911  877  789  856 
Female 15-49 years 1'097  1'094  1'092  1'089  1'087  991  900  771 

Number of reported cases

(Click for retrospective incidence data for New Zealand)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  103  10  280  68  65 
Mumps
ChartChart
  20  13  18  23  26  50 
Pertussis
ChartChart
  1'096  1'168  1'099  3'396  5'598  4'143  91 
Polio*
ChartChart
 
Rubella
ChartChart
  26 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for New Zealand)
Vaccine year result method % card seen                                                
BCG          13  20 
DTP1          92  93  93  93  94  89 
DTP3          92  92  93  92  93  90  90  76 
DTP4          88  87  84 
IPV1          92  93  93 
HepB_BD          89 
HepB3          92  92  93  93  93  90 
Hib3          92  92  93  92  93  90 
JapEnc         
MCV1          92  93  93  92  92  85  90  80 
MCV2          89  87  86  86  85 
MenA         
PCV1          95  93  93  94  93 
PCV2          94  93  93  93  93 
PCV3          93  93  93  93  92 
Pol3          92  92  93  92  93  82 
Rota1          67 
RotaC          66 
RCV1          92  93  93  92 
TT2plus          25 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for New Zealand)
DTP1
ChartChart
  92  93  93  93  94  96  96  91 
DTP3
ChartChart
  92  92  93  92  93  90  90  76 
HepB3
ChartChart
  92  92  93  93  93  90 
HepB_BD
ChartChart
 
Hib3
ChartChart
  92  92  93  92  93  90 
MCV1
ChartChart
  92  93  93  92  92  85  90  80 
MCV2
ChartChart
  89  87  86  86  85 
PCV3
ChartChart
  93  93  93  93  92 
Pol3
ChartChart
  92  92  93  92  93  82  90 
RCV1
ChartChart
  92  93  93  92  92  85  90  80 
RotaC
ChartChart
  66 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 95
From 80 to 89% 5
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 6 weeks Yes For infants at increased risk of tuberculosis
DTaPHibHepIPV 6 weeks; 3, 5 months; Yes and other eligible individuals
DTaPIPV 4 years; Yes and other eligible individuals
HepA x2 doses Yes specific risk groups
HepB Yes specific risk groups
Hib 15 months; 4 years; Yes and other eligible individuals
HPV 9-20 years (x2 or 3); Yes
Influenza_Adult >= 65 years; Yes And adults with chronic diseases, pregnant women, health care workers
Influenza_Pediatric Yes At risk children
IPV Yes eligible individuals
MenACWY Yes eligible individuals
MenC_conj Yes Specific risk groups
MMR 15 months; 4 years; Yes and other eligible individuals
Pneumo_conj 6 weeks; 3, 5, 15 months; Yes and other eligible individuals
Pneumo_ps Yes eligible individuals
Rotavirus 6 weeks; 3, 5 months; Yes
Td 45, 65 years; Yes and other eligible individuals
Tdap 11 years; Yes and other eligible individuals
Varicella Yes eligible individuals

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 20    20  20  20     

System performance

Total Nº districts in country number 20  20  20  20  20  20  20 
Nº districts with DTP3 coverage >=80% number 20  20           
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100           
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100% 15           

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.